Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 2
Submit an article Journal homepage
184
Views
52
CrossRef citations to date
0
Altmetric
Reviews

Oncolytic measles virus strains in the treatment of gliomas

Cory Allen Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Georgia Paraskevakou Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD,
Chunsheng Liu Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD,
Ianko D Iankov Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD PhD,
Pavlos Msaouel Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Paula Zollman Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Rae Myers Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Kah Whye Peng Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Stephen J Russell Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
&
Evanthia Galanis Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]; Mayo Clinic, Division of Medical Oncology, 200 First Street SW, Rochester, MN 55905, USA
, MD show all
Pages 213-220 | Published online: 14 Jan 2008

Bibliography

  • Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-30
  • Galanis E, Buckner JC. Diffuse cerebral gliomas in adults. In: Neurological Therapeutics: Principles and Practice. Noseworthy JH, editor. Abingdon: Informa Healthcare; 2006. p. 832-53
  • Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75(2):295-305
  • Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67(10):6025-32
  • Ulasov IV, Tyler MA, Zheng S, Han Y, Lesniak MS. CD46 represents a target for adenoviral gene therapy of malignant glioma. Hum Gene Ther 2006;17: 556-64
  • Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000;406(6798):893-7
  • Cutts FT, Markowitz LE. Successes and failures in measles control. J Infect Dis 1994;170(Suppl 1):s32-41
  • Greentree LB. Hodgkin's disease: therapeutic role of measles vaccine. Am J Med 1983;75(6):928
  • Schattner A. Therapeutic role of measles vaccine in Hodgkin's disease. Lancet 1984;1(8369):171
  • Galanis E, Bateman A, Johnson K, et al. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum Gene Ther 2001;12(7):811-21
  • Collatz E, Von Kleist S, Burtin P. Further investigations of circulating antibodies in colon cancer patients: on the autoantigenicity of the carcinoembryonic antigen. Int J Cancer 1971;8(2):298-303
  • Ura Y, Ochi Y, Hamazu M, et al. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients. Cancer Lett 1985;25(3):283-95
  • Dabbs DJ. Diagnostic Immunohistochemistry. Churchill Livingstone, Philadelphia, PA; 2002
  • Ishikura A, Hunaki N, Watanabe K. Brain metastases of colorectal cancer – a case report. Gan No Rinsho 1987;33(2):188-92
  • Peng KW, Teneyck CJ, Galanis E, et al. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 2002;62(16):4656-62
  • Peng KW, Facteau S, Wegman T, O'Kane D, Russell SJ. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med 2002;8(5):527-31
  • Phuong LK, Allen C, Peng KW, et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 2003;63(10):2462-9
  • Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004;64(14):4919-26
  • Mcquaid S, Cosby SL. An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab Invest 2002;82(4):403-9
  • Shusta EV, Zhu C, Boado RJ, Pardridge WM. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol 2002;61(7):597-604
  • Giannini C, Sarkaria JN, Saito A, et al. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 2005;7(2):164-76
  • Mrkic B, Pavlovic J, Rulicke T, et al. Measles virus spread and pathogenesis in genetically modified mice. J Virol 1998;72(9):7420-7
  • Driesse MJ, Vincent AJ, Sillevis Smitt PA, et al. Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates. Gene Ther 1998;5(8):1122-9
  • Myers R, Harvey ME, Greiner SM, et al. Safety of repeat intracerebral administration of MV-CEA in Rhesus macaques in support of a Phase I/II clinical trial for patients with recurrent gliomas. Mol Ther 2006;13(Suppl 1):s113 (Abstract 297)
  • Maenpaa A, Junnikkala S, Hakulinen J, et al. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am J Pathol 1996;148:1139-52
  • Shinoura N, Heffelfinger SC, Miller M, et al. RNA expression of complement regulatory proteins in human brain tumors. Cancer Lett 1994;86:143-9
  • Allen C, Vongpunsawad S, Nakamura T, et al. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 2006;66(24):11840-50
  • Paraskevakou G, Allen C, Nakamura T, et al. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas. Mol Ther 2007;15(4):677-86
  • Nakamura T, Peng KW, Harvey M, et al. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 2005;23:209-14
  • Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 2004;78(1):302-13
  • Allen C, Paraskevakou G, Iankov I, et al. IL13 displaying retargeted oncolytic measles virus (MV) strains have significant activity and improved therapeutic index against gliomas. Mol Ther 2007;15(Suppl 1):s22 (Abstract 51)
  • Liu C, Sarkaria JN, Allen C, et al. Combination of oncolytic measles virus strains and radiation therapy has synergisitic activity in the treatment of glioblastoma multiforme. Clin Cancer Res 2007;13(23):7155-65
  • Schowalter RM, Wurth MA, Aguilar HC, et al. Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell-cell fusion. Virology 2006;350(2):323-34
  • Immonen A, Vapalahti M, Tyynela K, et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 2004;10(5):967-72
  • Lang FF, Bruner JM, Fuller GN, et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003;21(13):2508-18
  • Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997;3(12):1354-61
  • Chiocca EA, Abbed KM, Tatter S, et al. A Phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 2004;10(5):958-66
  • Freeman AI, Zakay-Rones Z, Gomori JM, et al. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 2006;13(1):221-8
  • Markert JM, Medlock MD, Rabkin SD, et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a Phase I trial. Gene Ther 2000;7(10):867-74
  • Forsyth PA, Roldan G, George D, et al. A Phase I trial of intratumoral (i.t.) administration of reovirus in patients with histologically confirmed recurrent malignant gliomas (MGs). ASCO Ann Meeting Proc Part I 2006;24(18s):1563
  • Dingli D, Peng KW, Harvey ME, et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004;103(5):1641-6
  • Iankov ID, Blechacz B, Liu C, et al. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy. Mol Ther 2007;15(1):114-22
  • Wei J, Wahl J, Nakamura T, et al. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas. Gene Ther 2007;14(22):1573-86

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.